
Accuray Incorporated ARAY
$ 0.33
-9.9%
Quarterly report 2026-Q3
added 05-06-2026
Accuray Incorporated Total Non Current Liabilities 2011-2026 | ARAY
Annual Total Non Current Liabilities Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 196 M | 161 M | 75.4 M | 199 M | 224 M | 212 M | 213 M | 95.1 M | 12.4 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 224 M | 12.4 M | 154 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 12.76 | -10.87 % | $ 361 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 7.98 | 0.69 % | $ 1.2 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.11 | -3.91 % | $ 18.8 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 1.22 | -12.86 % | $ 26.9 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.44 | -9.22 % | $ 27.4 M | ||
|
LivaNova PLC
LIVN
|
516 M | $ 73.19 | -0.72 % | $ 3.99 B | ||
|
LENSAR
LNSR
|
3.44 M | $ 5.58 | -0.8 % | $ 66.7 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 18.35 | 1.38 % | $ 430 M | ||
|
Pulmonx Corporation
LUNG
|
25 M | $ 1.52 | -6.17 % | $ 61.8 M | ||
|
MiMedx Group
MDXG
|
65.4 M | $ 3.8 | 0.4 % | $ 562 M | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 10.66 | -1.25 % | $ 382 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Myomo
MYO
|
275 K | $ 1.25 | -2.35 % | $ 52.3 M | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
9.02 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
8.87 K | $ 38.16 | 3.91 % | $ 323 M | ||
|
Profound Medical Corp.
PROF
|
2.44 M | $ 6.78 | -0.15 % | $ 205 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
83.1 M | $ 10.42 | 0.77 % | $ 413 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 81.01 | 1.26 % | $ 11 B | ||
|
Insulet Corporation
PODD
|
1.06 B | $ 153.69 | 4.97 % | $ 10.8 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 35.43 | 0.83 % | $ 1.1 B | ||
|
Sintx Technologies
SINT
|
1.76 M | $ 2.11 | -6.03 % | $ 5.85 M | ||
|
Inspire Medical Systems
INSP
|
24.6 M | $ 41.39 | -1.84 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 92.64 | -0.02 % | $ 3.22 B | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 85.71 | -1.97 % | $ 50.1 B |